Pamela Vath

Medical Science Liaison- NorthEast at Ocular Therapeutix - Bedford, MA, US

Pamela Vath's Colleagues at Ocular Therapeutix
Andrew Tenney

Director of Commercial Operations

Contact Andrew Tenney

Mark Neira

Market Access Marketing Manager & Head of Training

Contact Mark Neira

Shannon Crittenden

Quality Assurance Specialist III

Contact Shannon Crittenden

Christina O'Neill

Senior Director Manufacturing

Contact Christina O'Neill

Steven Lu

Senior Manager, Research and Development

Contact Steven Lu

View All Pamela Vath's Colleagues
Pamela Vath's Contact Details
HQ
781-357-4000
Location
North Reading, Massachusetts, United States
Company
Ocular Therapeutix
Pamela Vath's Company Details
Ocular Therapeutix logo, Ocular Therapeutix contact details

Ocular Therapeutix

Bedford, MA, US • 250 - 499 Employees
Major Drugs

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix's lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed Phase 3 clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase 3 clinical development for the reduction of intraocular pressure in patients with glaucoma and ocular hypertension. The Company's earlier stage assets include OTX-TIC, a sustained release travoprost intracameral injection for the reduction in intraocular pressure in patients with glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. These injections include the development of OTX-TKI, a tyrosine kinase inhibitor (TKI), and, in collaboration with Regeneron, an extended release protein-based anti-vascular endothelial growth factor (VEGF) trap. Ocular Therapeutix's first product, ReSure® Sealant, is FDA-approved to seal corneal incisions following cataract surgery.

ocular drug delivery surgical sealants sustained delivery ophthalmic therapies ophthalmology optometry retina cataract glaucoma wet AMD anti-vegf drug delivery B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals Biotech Pharmaceuticals
Details about Ocular Therapeutix
Frequently Asked Questions about Pamela Vath
Pamela Vath currently works for Ocular Therapeutix.
Pamela Vath's role at Ocular Therapeutix is Medical Science Liaison- NorthEast.
Pamela Vath's email address is ***@ocutx.com. To view Pamela Vath's full email address, please signup to ConnectPlex.
Pamela Vath works in the Major Drugs industry.
Pamela Vath's colleagues at Ocular Therapeutix are Andrew Tenney, Stephen DiRico, Mark Neira, Shannon Crittenden, Annette Stanford, Christina O'Neill, Steven Lu and others.
Pamela Vath's phone number is 781-357-4000
See more information about Pamela Vath